Elkan Gamzu, PhD, Chairman of Hygeia’s Board of Directors
Dr. Gamzubrings to Hygeia more than 25 years
experience in the pharmaceutical industry having held key management and
executive roles at EPIX, Pharmos, Hypnion, XTL Biopharmaceuticals, Millennium
Pharmaceuticals, Warner-Lambert, Hoffman-LaRoche and Cambridge
Neurosciences. Dr Gamzu is a principal of enERGetic Biopharmaceutical
Consultancy and was a founding partner of BioPharmAnalysis.
Dr. Gamzu is a graduate of Hebrew University in Jerusalem and earned his Master’s and PhD degrees in experimental and physiological psychology from the University of Pennsylvania.
Wulf H. Utian, MD, PhD, DSc (Med) Chairman of Hygeia’s Advisory Board
Dr. Utian is the Executive Director and Honorary Founding President of The North American Menopause Society (NAMS). Dr. Utian is considered to be one of the significant authorities on menopause and women’s health issues. He is Board Certified in Obstetrics and Gynecology and Reproductive Endocrinology, and is a Fellow of the Royal College of Obstetricians and Gynaecologists, the American College of Obstetrics and Gynecology and the International College of Surgeons. He is the recipient of multiple research grants and has authored more than 200 papers and 5 books related to women’s health and menopause. He is the Editor of Menopause and Menopause Management.
Dr. Utian received his medical degree from the University of the Witwatersrand, Johannesburg, South Africa, and his PhD from the University of Cape Town, South Africa. In 2007, he earned the DSc (Med) degree from the University of Cape Town, its highest degree and only awarded 11 times over the past 100 years.
Tania Philips, MD, FRCPC
Dr. Phillips completed her medical training at Guys Hospital Medical School, University of London, England. After becoming a member of the Royal College of Physicians, she trained in Dermatology at the London Hospital and also had an appointment at St. John’s Hospital for Diseases of the Skin. She subsequently joined the faculty at Boston University School of Medicine where she is Professor of Dermatology.
Dr. Phillips is an international expert on the role of estrogens in wound healing and skin aging. She is the Director of the Wound Healing Clinic at Boston Medical Center. She has co-authored 3 books and over 250 scientific publications in dermatology. Richard Hochberg, PhD
Dr. Hochberg is Professor of Obstetrics /Gynecology and Reproductive Sciences and of the Comprehensive Cancer Center at Yale University School of Medicine. He is the inventor of Hygeia’s compounds and holds 5 patents. He is currently Editor-in-Chief of the journal, Steroids, and has authored two book chapters on Steroidogenesis and Hormonal Therapy for Epithelial Ovarian Cancer. In 1991, he co-edited the book, The New Biology of Steroid Hormones.
Dr. Hochberg received his PhD in Biochemistry from Hahnemann Medical College, Philadelphia, Pennsylvania after which he was a postdoctoral fellow at the NIH.
Machelle (Mache) Seibel, MD
Dr Seibel spent nearly two decades on the Harvard Medical School faculty before taking his current position as Professor of Obstetrics and Gynecology and Director of the Complicated Menopause Program at the University of Massachusetts Medical School. Dr. Seibel has won national awards for research, writing, and patient education. His clear and concise summaries of complex issues have made him a consistent figure in both print and broadcast media, and a sought after advisor.
Dr Seibel has conducted many published clinical trials, testified before the FDA, and been invited to speak to the U.S. Department of Health and Human Services. He has written or edited 10 scholarly books and authored or co- authored more than 200 scientific articles. Dr. Seibel has been featured in People Magazine, Inside Edition, Discover Magazine, the Boston Globe and the New York Post and is regularly interviewed by major print, radio and broadcast media on a wide variety of health issues. He is the recipient of both the Searle - Donald F. Richardson Focus on Patient Education Award from the American College of Obstetrics and Gynecology, and the Consumer Education Award from the American Society for Reproductive Medicine for his ground breaking work in patient education. Dr. Seibel is repeatedly voted by his peers into Woodward and White’s Best Doctors in America, and is a member of the American Cancer Society’s New England Division Medical Advisory Network. In 2008 the UTMB School of Medicine Alumni Association Board of Trustees named him a Distinguished Alumnus Award recipient.
Dr. Seibel is also an award-winning composer and founder of HealthRock®, teaching health literacy through music and entertainment.
ACADEMIC ADVISORS
H. Maurice Goodman, PhD
Dr. Goodman received his PhD in Physiology from Harvard University in 1960. He was Professor and Founding Chairman of the Physiology Department at the University of Massachusetts Medical School. At the University of Massachusetts Medical School he also served as Acting Provost, Deputy Dean, Acting Chancellor and Associate Dean for Scientific Affairs. He was awarded the Distinguished Service Medal by the Trustees of the University and was the 2005 recipient of the Lamar Soutter Award for excellence in medical education. Dr. Goodman has authored nearly 200 original scientific publications in Endocrine physiology and was Editor-in-Chief of the five-volume Endocrinology Section of the Handbook of Physiology. He has served on the editorial review boards of Endocrinology and Endocrine Reviews and was Associate Editor of the Journal of Clinical Endocrinology and Metabolism. His textbook, Basic Medical Endocrinology, is now in its 4th edition.
Steven Cohen, DSc
Dr. Cohen is Professor of Pharmacology and Toxicology and Chair of the Department of Pharmaceutical Sciences at the Massachusetts College of Pharmacy and Health Sciences. Dr. Cohen is Professor Emeritus at the University of Connecticut School of Pharmacy. He earned his DSc degree in Toxicology from Harvard University in 1970. He is past president of SOT and is Specialty Editor for Toxicology and Applied Pharmacology. Dr. Cohen has served on both scientific review and advisory panels concerned with toxicological risk assessment for government and industry. He is the recipient of numerous awards for excellence in teaching and research and has authored hundreds of seminal papers in the mechanisms of organ toxicity.